Download | < Back |
05 Apr 2017 | |
Pursuant to Regulation 13(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are furnishing the below statement showing the status of Investor Complaints of the Company for the quarter ended March 31, 2017 Pending at beginning of quarter - Nil Received during quarter - 3 Disposed during quarter - 3 unresolved at end of quarter - Nil | |
View all announcements for DR.REDDY'S LABORATORIES LTD. | Source: BSE India |